GE HealthCare Technologies GEHC PCS — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GE HealthCare Technologies in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about GE HealthCare Technologies's pcs — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GE HealthCare Technologies's PCS — cost of sales?
- GE HealthCare Technologies (GEHC) reported PCS — cost of sales of $481M in Q1 2026.
- How has GE HealthCare Technologies's PCS — cost of sales changed year-over-year?
- GE HealthCare Technologies's PCS — cost of sales decreased by 0.0% year-over-year, from $481M to $481M.
- What is the long-term trend for GE HealthCare Technologies's PCS — cost of sales?
- Over 3 years (2022 to 2025), GE HealthCare Technologies's PCS — cost of sales has grown at a 3.3% compound annual growth rate (CAGR), from $1.84B to $2.03B.
- What does PCS — cost of sales mean?
- Includes the direct costs attributable to the production and delivery of Patient Care Solutions products, such as raw materials, direct labor, and manufacturing overhead. Monitoring this helps assess the segment's manufacturing efficiency and exposure to supply chain inflation.